Company profilePharmaceutical#490 of 1,318 in Pakistan✓ No DRAP alerts

Le Mendoza Pharmaceutical (Pvt) Ltd.

Pharmaceutical company · 28 brands · 18 molecules

28 registered products 23 pharmaceutical brands 18 distinct molecules 0 DRAP alerts

Company overview

28
registered products
23
pharmaceutical brands
18
distinct molecules
0
therapeutic classes
0
DRAP alerts

Le Mendoza Pharmaceutical (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 28 product registrations across 18 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Le

14 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

14
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202514

Top molecules by brand count

Azithromycin3 brands
Folic Acid2 brands
Clarithromycin ...... 125 Mg1 brand
Azithromycin ...... 500 Mg1 brand
Tranexamic Acid ...... 100 Mg1 brand
Ciprofloxacin ..... 3Mg ...... 3 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official28 products · Rs 75.05 – Rs 1,078.61
Median across source: Rs 416.68

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

HIGH - Q INTERNATIONAL holds 134 molecules not in this portfolio
000 I.UAcetyl L-CarnitineAmikacinAmlodipineAnastrozoleAprepitant
GENOME PHARMACEUTICALS (PVT) LTD holds 107 molecules not in this portfolio
AcitretinAmlodipineAnastrazoleAnastrozoleAprepitantArtemether
IRZA PHARMA (PVT) LTD. holds 111 molecules not in this portfolio
AcetazolamideAcyclovirAdrenalineAlbendazoleAlbuterolAmikacin

Get the full profile for Le

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.